Results of a new medication, Retatrutide, showed the highest amount of weight loss in a clinical trial so far
These effects have been consistently observed across commonly used GLP-1RAs, including semaglutide and liraglutide
The insulin syringe dosage guide covers the markings and measurements in detail
doi: 10.1038/sj.ijo.0802696 144 BoeyDSainsburyAHerzogH
(28) There were no statistically significant differences in amputation risk between GLP-1s, SGLT-2 inhibitors, DPP4-Is, and all other agents
36 In some situations, the specific risk factor may have been mitigated and is no longer a concern (e.g., a high triglyceride level that is now within normal range, previous excess alcohol use in a patient who is currently sober, history of gallstones since resolved by cholecystectomy)